- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06134505
Evaluation of the Efficiency of Local Application of Bee Products in the Care of Diaper Dermatitis in Infants
January 12, 2024 updated by: İlknur KAHRİMAN, Karadeniz Technical University
The aim of this study was to evaluate the local application of bee products in the care of diaper dermatitis in infants.
- H1: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than barrier cream 2 containing zinc oxide.
- H2: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than olive oil.
- H3: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, compared to babies who use barrier cream 2, which contains zinc oxide.
- H4: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, than babies who use olive oil.
Study Overview
Status
Completed
Conditions
Detailed Description
Diaper dermatitis is one of the most common dermatological problems of infancy.
Diaper dermatitis constitute from approximately 25% of visits to primary health care services for dermatological complaints in the first year of life.
The ABCDE rule is based on the prevention of diaper dermatitis.
According to ABCDE rule; airing the bottom of babies with diaper dermatitis, changing diapers hourly in the newborn period, every 3-4 hours in infancy, cleaning using warm water or wet wipes sucked with water, applying barrier creams in a thin layer after cleaning the area, and protecting from diaper dermatitis and providing diaper hygiene.
Families should be educated on the right skin care practices.
This thesis study was conducted in a randomized control experimental design in order to investigate the effect of olive oil, 40% zinc oxide, propolis, royal jelly, perga and plant oil mixture on the healing process in the care of 1-6 months old infants with first degree diaper dermatitis who applied to the Family Health Center/ Child Outpatient Clinic.
The population of the study will be 1-6 month old babies with first degree diaper dermatitis who are registered to Family Health Centers in Antalya's Kumluca district and applied to the pediatric outpatient clinic of Kumluca State Hospital.
The sample of the study was consisted of 93 infants (Olive oil: 31, propolis, beeswax, queen bee larva and plant oil mixture: 31, 40% zinc oxide cream: 31) registered to the Family Health Center and and applied to Kumluca State Hospital between January 2022 and December 2023, aged 1-6 months and meeting the sample selection criteria.
The data were collected using the "Parent-Infant Descriptive Information Form", "Observation Forms", and "Assessing the Severity of Uncomplicated Diaper Dermatitis" in Infants Scale in Infants, after obtaining the permission of the ethics committee and institution of the research.
The data was evaluated using the SPSS 23 package program.
Study Type
Interventional
Enrollment (Actual)
93
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kumluca/Antalya
-
Antalya, Kumluca/Antalya, Turkey, 07000
- Antalya Provincial Directorate of Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Infants aged 1-6 months registered at Family Health Centers No. 1, No. 2 and No. 3,
- Infants aged 1-6 months admitted to Kumluca State Hospital's Pediatric Outpatient Clinic,
- Infants with grade one diaper dermatitis according to the Uncomplicated Diaper Dermatitis in Infants Severity Rating Scale,
- Breastfed babies,
- Babies without antibiotics,
- Families who do not regularly use protective barrier cream/oil for diaper dermatitis care,
- Babies who have not started supplementary food,
- Babies with no other dermatologic or allergic skin conditions,
- Families who agreed to participate in the study were included.
Exclusion Criteria:
- Babies who are not registered to the Family Health Centers where the research was conducted,
- Newborns and babies older than 6 months who apply to the Pediatric Outpatient Clinic of Kumluca State Hospital,
- Babies who do not have first degree diaper dermatitis according to the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants,
- Babies fed with breast milk + formula or only formula,
- Babies using antibiotics,
- Families who regularly use protective barrier cream/oil in diaper dermatitis care,
- Babies who switch to solid food,
- Babies with dermatological or other allergic skin problems,
- Babies using antimycotic drugs (Ampotericin etc.),
- Babies who use a bladder for a long time,
- Babies with urinary incontinence due to diseases such as meningomyolocele and cerebral palsy,
- Families who did not agree to participate in the research were not included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental: Experimental Group2
Olive oil group
|
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants.
After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out.
Families were provided with education based on the ABCDE model.
Mothers were informed that olive oil would be used at each diaper change.
Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form.
Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
|
Experimental: Experimental: Experimental Group1
Barrier cream group 1 consists of a mixture of propolis, beeswax, queen bee larva and plant oil
|
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants.
After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out.
Families were provided with education based on the ABCDE model.
Mothers were informed that Barrier cream 1 would be used at each diaper change.
Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form.
Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
|
Active Comparator: Control Group
Barrier cream group 2 consists of zinc oxide
|
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants.
After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out.
Families were provided with education based on the ABCDE model.
Mothers were informed that barrier cream 2 would be used at each diaper change.
Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form.
Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scale for Assessing the Severity of Uncomplicated Diaper Dermatitis in Infants
Time Frame: 5 minutes
|
The score to be received from each item of the scale varies between "0-6".
The highest and lowest scores that can be obtained from the items are 0-3 points in the "Severity of Erythema or Irritation" item, 0-1 point in the "Extent of Diaper Dermatitis" item, 0-1 point in the "Papules and Pustules" item, and 0-1 point in the "Light Skin" item.
It is between 0-1 points.
Low total scores from the scale indicate that the severity of diaper dermatitis is low, and high scores indicate that the severity of diaper dermatitis is high.
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ilknur Kahriman, Assoc. Prof., Karadeniz Technical University
- Principal Investigator: Bahar Aksoy, MAster, Karadeniz Technical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 24, 2022
Primary Completion (Actual)
November 8, 2023
Study Completion (Actual)
November 8, 2023
Study Registration Dates
First Submitted
November 7, 2023
First Submitted That Met QC Criteria
November 10, 2023
First Posted (Actual)
November 18, 2023
Study Record Updates
Last Update Posted (Estimated)
January 17, 2024
Last Update Submitted That Met QC Criteria
January 12, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- İlknurKahriman
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
IPD Sharing Time Frame
12 months after publication
IPD Sharing Access Criteria
Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diaper Dermatitis Healing
-
University of the PhilippinesCalmoseptine, Inc.CompletedDiaper DermatitisPhilippines
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Linda FuAvadim Technologies, Inc.Terminated
-
Genesis Health SystemUnknownDermatitis, ContactUnited States
-
Kimberly-Clark CorporationCompleted
-
University of PittsburghRobert Morris UniversityCompletedPostoperative Complications | Ileostomy - Stoma | Perianal Dermatitis | Diaper Dermatitis | Colostomy SiteUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Karamanoğlu Mehmetbey UniversityCompleted
-
Cooperation Pharmaceutique FrancaiseClin-ExpertsCompleted
Clinical Trials on Use of olive oil in the healing of diaper dermatitis
-
The Dental Hospital of Zhejiang University School...RecruitingMechanical Failure of Dental Implant NosChina
-
Western Galilee Hospital-NahariyaRecruiting
-
Universidade do PortoNot yet recruiting
-
Helena PiccininiNova Scotia Health AuthorityWithdrawnGestational Weight GainCanada
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
The First Affiliated Hospital with Nanjing Medical...The First Affiliated Hospital of Soochow UniversityRecruitingthe Application of Artificial Intelligence in the Diagnosis of Prostate CancerChina
-
Vanderbilt UniversityCompletedGlaucomaUnited States
-
West China HospitalBeijing Tiantan Hospital; First Affiliated Hospital of Chongqing Medical University and other collaboratorsCompletedStroke | Cardiovascular Disease | Primary PreventionChina
-
Istituto Clinico HumanitasCompletedEndoscopic Transmural Drainage of Pancreatic Fluid Collections
-
Central Hospital, Nancy, FranceNot yet recruitingExposure, RadiationFrance